Intra-Cellular Therapies, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Intra-Cellular Therapies, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Intra-Cellular Therapies, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $14M, a 4.84% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $14M +$647K +4.84% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $14.5M +$720K +5.22% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $12.5M -$1.72M -12.1% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $12.9M -$1.9M -12.8% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $13.4M -$6.71M -33.4% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $13.8M -$6.69M -32.7% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $14.2M -$3.77M -21% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $14.8M -$5.94M -28.6% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $20.1M -$1.64M -7.54% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $20.5M -$2.07M -9.18% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $18M -$5.46M -23.3% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $20.8M -$3.56M -14.6% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $21.7M -$2.58M -10.6% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $22.5M +$2.28M +11.2% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $23.4M +$5.38M +29.8% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $24.3M +$6.07M +33.3% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $24.3M +$5.75M +31% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $20.3M +$1.45M +7.69% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $18.1M -$2.05M -10.2% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $18.3M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $18.5M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $18.8M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $20.1M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.